Compare TLSI & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSI | JAKK |
|---|---|---|
| Founded | 2010 | 1995 |
| Country | United States | United States |
| Employees | 102 | N/A |
| Industry | Medical Specialities | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.2M | 254.1M |
| IPO Year | N/A | 1996 |
| Metric | TLSI | JAKK |
|---|---|---|
| Price | $3.15 | $21.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 590.8K | 44.0K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $331,249,000.00 |
| Revenue This Year | $35.45 | $9.46 |
| Revenue Next Year | $37.58 | $4.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.20 | $14.87 |
| 52 Week High | $7.95 | $24.45 |
| Indicator | TLSI | JAKK |
|---|---|---|
| Relative Strength Index (RSI) | 36.08 | 44.01 |
| Support Level | N/A | $19.61 |
| Resistance Level | $5.41 | $23.00 |
| Average True Range (ATR) | 0.33 | 0.97 |
| MACD | -0.17 | -0.24 |
| Stochastic Oscillator | 38.93 | 27.06 |
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.